Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.ASTH · Entity 4538 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,188 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 4,525 · Balance 18,188 F1: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. F2: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
F2: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MARVELL TECHNOLOGY GROUP LTD
Report date October 24, 2017 · Filed October 25, 2017
Jointly reported with Sutardja, Sehat
Section 16 reporting ended · disclosed 2017-10-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | IndirectBy Sutardja Family LLC | 7,199,378 |
Reported balance
After 2017-10-24 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-10-24 · Sale · Disposed 6,059,353 · Balance 7,199,378 F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.59, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company. |
| Common SharesSEC Table I · non-derivative | IndirectBy SSWD LLC | 39,832,511 |
Reported balance
Holding disclosure · report date 2017-10-24 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 39,832,511 F2: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F4: Ms. Dai and Dr. Sutardja are the managing members of the SSWD LLC, a Delaware limited liability company. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.59, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.
F2: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife.
F3: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company.
F4: Ms. Dai and Dr. Sutardja are the managing members of the SSWD LLC, a Delaware limited liability company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 200,000 | $10.76 | $2,152,000.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 5 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,668,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 300,000 | $14.03 | $4,207,710.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 4 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.115, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Sahres | 300,000 | $6.84 | $2,052,000.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 3 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,768,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 29,332 | $14.03 | $411,401.83 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.115, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 29,332 | $6.84 | $200,630.88 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,498,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 16:34 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 47,527 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001209191-16-153365 · doc4.xml · derivative · entry 5 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,332 Underlying: Common Shares · 47,527 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 15, 2008, the vesting commencement date. F6 · balance_after: Dr. Sehat Sutardja is the husband of Ms. Weili Dai. Dr. Sutardja holds this option in his own name. Ms. Weili Dai may be deemed to be an indirect beneficial owner of this option. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 16:34 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 47,527 | $14.45 | $686,765.15 |
DisclosureSEC source: 0001209191-16-153365 · doc4.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $14.455, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 16:34 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 47,527 | $6.84 | $325,084.68 |
DisclosureSEC source: 0001209191-16-153365 · doc4.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,516,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:31 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 160,494 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001209191-16-153033 · doc4.xml · derivative · entry 8 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 160,494 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 15, 2008, the vesting commencement date. F8 · balance_after: Ms. Weili Dai is the wife of Dr. Sehat Sutardja. Ms. Weili Dai holds this option in her own name. Dr. Sehat Sutardja may be deemed to be an indirect beneficial owners of this option. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:31 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,641 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001209191-16-153033 · doc4.xml · derivative · entry 7 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,859 Underlying: Common Shares · 20,641 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 15, 2008, the vesting commencement date. F7 · balance_after: Dr. Sehat Sutardja is the husband of Ms. Weili Dai. Dr. Sutardja holds this option in his own name. Ms. Weili Dai may be deemed to be an indirect beneficial owner of this option. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:31 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 160,494 | $14.48 | $2,324,065.47 |
DisclosureSEC source: 0001209191-16-153033 · doc4.xml · nonDerivative · entry 4 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $14.52, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:31 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 160,494 | $6.84 | $1,097,778.96 |
DisclosureSEC source: 0001209191-16-153033 · doc4.xml · nonDerivative · entry 3 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,629,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:31 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 20,641 | $14.45 | $298,266.58 |
DisclosureSEC source: 0001209191-16-153033 · doc4.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $14.455, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:31 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 20,641 | $6.84 | $141,184.44 |
DisclosureSEC source: 0001209191-16-153033 · doc4.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,489,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 16:34 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 39,506 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001209191-16-152675 · doc4.xml · derivative · entry 5 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,494 Underlying: Common Shares · 39,506 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 15, 2008, the vesting commencement date. F6 · balance_after: Ms. Weili Dai is the wife of Dr. Sehat Sutardja. Ms. Weili Dai holds this option in her own name. Dr. Sehat Sutardja may be deemed to be an indirect beneficial owner of this option. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 16:34 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 39,506 | $14.45 | $570,992.07 |
DisclosureSEC source: 0001209191-16-152675 · doc4.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $14.475, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 16:34 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 39,506 | $6.84 | $270,221.04 |
DisclosureSEC source: 0001209191-16-152675 · doc4.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,508,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.